INCY vs IQV
Incyte vs IQVIA — AI-powered side-by-side comparison
| Metric | INCY | IQV |
|---|
| AI Score |
73
|
70
|
| Price |
$120.19
|
$236.69
|
| P/E Ratio |
14.78×
|
29.11×
|
| ROE |
24.9%
|
20.9%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
92.6%
|
26.2%
|
| Debt / Equity |
0.01×
|
2.63×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
51.8
|
64.6
|
| Beta |
0.769
|
1.175
|
| Expected Upside |
—
|
+4.2%
|
AI Committee View
Current Innellis committee reasoning for INCY versus IQV.
INCY leads by 3 points.
INCY scores 73/100 (Buy) versus IQV at 70/100 (Buy).
INCY Committee View
100% agreement
6 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- ROE of 29.6% shows genuine earnings power backing the valuation — Value
- Revenue growing 26.9% YoY -- genuine top-line momentum — Growth
- EPS growing 80.3% YoY — Growth
Bear Case
- MACD histogram negative -- bearish momentum — Technical
IQV Committee View
60% agreement
5 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Daily trend (uptrend) conflicts with the weekly trend (downtrend) -- fighting the larger trend — Technical
- Weekly RSI at 81 -- overbought on the larger timeframe too — Technical
- Bollinger bandwidth of 30.0% signals elevated volatility — Risk